Description
HIV p17 Gag (77-85) is an immunodominant Gag epitope peptide used to prime activated CD8+ cytotoxic T cells (CTLs) in the design of vaccines against HIV-1.
HIV p17 Gag (77-85) is an immunodominant Gag epitope peptide used to prime activated CD8+ cytotoxic T cells (CTLs) in the design of vaccines against HIV-1.
Purity | ≥98% |
---|---|
Formula | C44H72N10O15 |
Formula Wt. | 981.1 |
Synonym | HIV-1 p17 (77-85); SL9. |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet | H3274 Info Sheet PDF |
---|
Kan-Mitchell J, Bajcz M, Schaubert KL, et al. Degeneracy and repertoire of the human HIV-1 Gag p17(77-85) CTL response. J Immunol. 2006 Jun 1;176(11):6690-701. PMID: 16709828.
Kan-Mitchell J, Bisikirska B, Wong-Staal F, et al. The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope. J Immunol. 2004 May 1;172(9):5249-61. PMID: 15100263.